Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (621-630 of 1,104) with videos related to

Pageof 111
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2020
Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantationDanbee Kang, Im-Ryung Kim, Hye Jin Choi, et al.
Therapeutic Advances in Hematology|June 12, 2020
Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)Ja Min Byun, Sung-Soo Yoon, Youngil Koh, et al.
Blood Research|April 10, 2020
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndromeMihong Choi, Ja Yoon Heo, Dong-Yeop Shin, et al.
Development (Cambridge, England)|January 12, 2022
Cell trajectory modeling identifies a primitive trophoblast state defined by BCAM enrichmentMatthew J Shannon, Jennet Baltayeva, Barbara Castellana, et al.
Leukemia & Lymphoma|October 11, 2018
ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significanceDong-Yeop Shin, Jin-Kyun Park, Sung-Min Kim, et al.
Clinical Epigenetics|May 3, 2023
Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activationJun Liu, Suji Min, Dongchan Kim, et al.
Carbohydrate Polymers|January 1, 2020
Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivativeJae-Young Lee, Han Sol Lee, Nae-Won Kang, et al.
Blood|July 31, 2014
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myelomaAndrew Spencer, Sung-Soo Yoon, Simon J Harrison, et al.
International Journal of Hematology|May 3, 2013
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean RegistryJong Wook Lee, Jun Ho Jang, Jin Seok Kim, et al.
American Journal of Clinical Pathology|December 21, 2020
Ultradeep Sequencing Analysis of Paroxysmal Nocturnal Hemoglobinuria Clones Detected by Flow Cytometry: PIG Mutation in Small PNH ClonesDajeong Jeong, Hee Sue Park, Sung-Min Kim, et al.
Pageof 111

Showing results (621-630 of 1,104) with videos related to

Sort By:
Pageof 111
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2020
Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantationDanbee Kang, Im-Ryung Kim, Hye Jin Choi, et al.
Therapeutic Advances in Hematology|June 12, 2020
Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)Ja Min Byun, Sung-Soo Yoon, Youngil Koh, et al.
Blood Research|April 10, 2020
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndromeMihong Choi, Ja Yoon Heo, Dong-Yeop Shin, et al.
Development (Cambridge, England)|January 12, 2022
Cell trajectory modeling identifies a primitive trophoblast state defined by BCAM enrichmentMatthew J Shannon, Jennet Baltayeva, Barbara Castellana, et al.
Leukemia & Lymphoma|October 11, 2018
ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significanceDong-Yeop Shin, Jin-Kyun Park, Sung-Min Kim, et al.
Clinical Epigenetics|May 3, 2023
Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activationJun Liu, Suji Min, Dongchan Kim, et al.
Carbohydrate Polymers|January 1, 2020
Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivativeJae-Young Lee, Han Sol Lee, Nae-Won Kang, et al.
Blood|July 31, 2014
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myelomaAndrew Spencer, Sung-Soo Yoon, Simon J Harrison, et al.
International Journal of Hematology|May 3, 2013
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean RegistryJong Wook Lee, Jun Ho Jang, Jin Seok Kim, et al.
American Journal of Clinical Pathology|December 21, 2020
Ultradeep Sequencing Analysis of Paroxysmal Nocturnal Hemoglobinuria Clones Detected by Flow Cytometry: PIG Mutation in Small PNH ClonesDajeong Jeong, Hee Sue Park, Sung-Min Kim, et al.
Pageof 111